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1. Introduction 
The first adenylate cyclase-linked receptor showing 
a decreased affinity due to the presence of guanine 
nucleotides, was the glucagon receptor of rat liver 
plasma membr~es [1). Guanine nucleotidedependent 
modulation of agonist binding to a /3-adrenergic 
receptor, was initially shown in plasma membranes 
from cultured rat glioma cells (C6) [2], and has since 
been observed in membranes from frog erythrocytes 
[3f, and other cells [4,5]. Guanine nucleotide modu- 
lation has also been found for receptors [6-81, which 
on interaction with adenylate cyclase results in inhibi- 
tion. Although, the dependence on guanine nucleo- 
tides for /.l receptor-mediated activation of adenylate 
cyclase [9-l l] in avian erythrocyte membranes i  
well documented, the bind~g of agonists to the fl 
receptor has been reported to be unaffected by 
guanine nucleotides [ 12-141. To explain the absence 
of guanine nucleotide-mediated receptor modulation, 
and the lack of agonist-dependent desensitization of
adenylate cyclase, it has been proposed that avian 
erythrocyte membranes may lack an additions GTP 
binding protein present in other cells [IS]. This 
study aimed to clarify these controversial points. 
2. Mate&Is and methods 
2.1. Mater&& 
ATP, GTP, GDP, GMP, CAMP, Gpp(NH)p, GTP7S, 
Abbreviations: Gpp(NH)p, guanosine S’-(p, v-imino) triphos- 
phate; Gpp(CH,)p, guanosine 5’-@, r-methylene) triphos- 
phonate; GTPrS, guanosine S’-(3.~iot~phosp~te); GDP@, 
guanosine 5’ (2-t~odipho~hate); IHYP, iodohydroxy- 
pindolol; MOPS, 3-(N-morphohno)propanesuIfonic a id; DTT, 
dithiothreitol 
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Gpp(CHJp creatine kinase, creatine phosphate were 
purchased from Boehringer, Mannheim. (&)Propra- 
nolo1 was from Sigma, and Lisoproterenol was 
obtained from EGA Chemie, Steinheim. CDPPS was 
a gift from Dr F. Eckstein, Gottingen, phentolamine 
and (+)-HYP were generously supplied by Eli Lilly Co. 
and Dr F. Hauser, Sandoz AC, respectively. [cr-32P]- 
ATP (S-l 5 Cilmmol) and c [3H]AMP were from the 
Radiochemical Center, Amersham and (f)-[rz51]IHYP 
was obtained from New England Nuclear. All other 
chemicals were of the highest purity available. Doubly 
distilled water was used throu~out. 
Preparation of both pigeon and turkey membranes 
was essentially as in [9], omitting D-IT*.. Prior to 
lysis, the erythrocytes were resuspended (25% 
haemotocrit) and incubated in a Krebs phosphate 
buffer (Ca’+ free) contai~g 5 mM glucose, 0.1 mgfml 
streptomycin, 0.1 mgfml penicillin, 150 @g/l aprotinin 
for 1 h at 37°C. The membranes were stored in liquid 
Nz in a buffer containing 20 imOsm. phosphate, 
150 mM NaCI, 3 mM MgS04, 1 mM EDTA (pH 7.4) 
(buffer A). Protein was measured according to [ 161 
using bovine serum albumin as standard. 
2.2. Adenylate cyclase 
Adenylate cyclase activity was measured as in [ 17 ]
and c[~~P]AMP isolated according to [18]. 
2.3. &adrenergic weep tor 
Binding of [‘2SI]IHYP to pigeon or turkey ery- 
throcyte membranes was measured according to [2]. 
Pigeon or turkey erythrocyte membranes (20-50 pg) 
were incubated with 70-I 20 pM [1251]IHYP in 
* DTT was omitted throughout the membrane preparation 
and also for measurement of receptor binding and adenylate 
cyclase activity, since it interfered with binding of [“‘i]- 
IHYP to membranes 
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250 ~1 total vol. buffer A containing 10 PM phentol- 
amine [191 in the presence and absence of appropriate 
concentrations of Lisoproterenol and nucleotides 
for 6 min at 37’C. Specific binding (-80-90% total) 
was defined as the difference in amount of [‘251] - 
IHYP bound in the absence and presence of 20 nM 
HYP. The incubation was terminated by dilution with 
1 mL20 mM phosphate, 1mM MgS04 (pH 7.4) con- 
taining 0.1 mM (D,L)-propranolol, followed by vacu- 
um filtration through a Whatman GF/C filter. The 
reaction vessel was washed with a further 1 ml of the 
same solution and the filter rapidly washed with 25 ml 
of the same buffer.(propanalol mitted). All solu- 
tions were maintained at 37°C. The filters were placed 
in a Triton X-lOO-toluene-based scintillant and the 
bound [“‘I] IHYP measured in a /I-scintillation 
counter with an efficiency of 50%. Binding experi- 
ments were performed in duplicates. Purity and 
recovery of nucleotides on exposure to membranes 
were checked by thin-layer chromatography on PEI- 
cellulose sheets developed in 0.75 M LiCl. 
3. Results 
Typical results demonstrating guanine nucleotide- 
dependent modulation of L-isoproterenol binding to 
both turkey and pigeon erythrocyte membranes are 
shown in fig. 1. It can be seen that the shift in the 
[ ‘251]IHYP displacement curve to higher isoproterenol 
concentrations, induced by the presence of 10 I.IM 
LOG [L-ISOP~TE~~EM~_. M j 
Fig.1. Modulation by Gpp(NH)p of L-isoproterenol binding to 
pigeon (A) and turkey (B) erythrocyte membranes. Displace- 
ment of [‘251]iHYP-binding in the presence (e-e) and 
absence (o-o) of 10 PM Gpp(NH)p was measured with 
40 pg membrane protein and 147 pM (r)-[ rzaI] IHYP 
(pigeon) and 50 pg membrane protein and 250 pM (+)-[1251]- 
IHYP (turkey) as in section 2. 
Table 1 
Effect of various nucleotides on displacement by 
L-isoproterenol of specific [ 1*51]IHYP-binding to pigeon 
erythrocyte membranes 
Nucleotide Q.IM) Shift of EC,, for L-isoproter- 
enol alone (-fold) 
GPP(NH)P 10 3.6 
GTP 0.1 2.5 
GTP 10 3.7 
GDPa 1 3.55 
GMP 1000 2.9 
GPP(CH,)P, 80 3.2 
GTPrS 0.1 3.65 
GTP(3S 100 3.6 
ATP 1000 2.2 
a GDP was degraded by <5% (to GMP) under the conditions 
applied 
Binding experiments were done with the same batch of 
membranes (35 rg/assay) as in section 2. 
GppHNp, is about the same for membranes from 
either species, i.e., for pigeon erythrocyte membranes, 
the ECso for Lisoproterenol is shifted from 1 .OS-3.5 
PM, and for turkey membranes from 2.5-7.1 PM. 
The magnitude of this shift varies for different mem- 
brane preparations and is dependent on the nature 
and concentration ofthe nucleotide. For pigeon eryth- 
rocyte membranes, the observed shift corresponds 
to a change in the app. Kd for L-isOprOkrt?nd from 
0.6-2.1 MM, based on a Kd for (-)-[1251]IHYP of 
120 pM, measured by equilibrium binding. The K,,, 
for L-isoproterenol and pigeon erythrocyte adenylate 
cyclase in the presence of 10 PM GTP, is 2 PM. In 
contrast o guanosine triphosphates and its analogues 
GDP and its derivatives, although tightly bound, 
inhibit adenylate cyclase [11,20,21]. We have there- 
fore studied the ability of various nucleotides to 
affect Lisoproterenol binding in pigeon erythrocyte 
membranes. Table 1 indicated that guanine nucleo- 
tide modulation of P-receptor affinity exhibits spe- 
cificity which is different from that for adenylate 
cyclase activation. The partial efficacy of ATP to 
cause modulation must be viewed with caution, as, 
although no regenerating system was included, the 
possibility of trace contaminants of guanine nucleo- 
tides which could be converted to GDP or GTP, by 
membrane-bound phosphotransferases cannot be 
excluded. 
Using plasma membranes from S49 lymphoma 
cells, it was demonstrated [5] that, unlike activation 
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Fig.2. Binding of L-isoproterenol to pigeon erythrocyte mem- 
branes: reversibility of nucleotide modulation. Membranes 
(2 mg/ml) in buffer A were preincubated with 10 PM 
L-isoproterenol and with (o,=) or without (0) 10 PM Gpp- 
(NH)p or 1 PM CTPrS at 37°C for 10 min. Membranes were 
washed 3 times with 10 vol. buffer A at 37°C. Binding of 
[‘251]IHYP in the presence of L-isoproterenol was done 
with 40 i.tg membrane protein as in section 2. With mem- 
branes pretreated with nucleotide, binding was done in the 
absence (o-o) and presence (a-a) of 10 /.IM Gpp(NH)p. 
(A) Membranes preincubated in the presence (o,e) or absence 
(0) of 10 PM Gpp(NH)p. (B) Membranes preincubated in the 
presence (o,=) or absence (=) of 1 PM GTP-yS. 
of adenylate cyclase by GppNHp, modulation of 
agonist binding induced by the same ligand could be 
reversed on washing the membranes, thus inferring 
some uncoupling of the two events. Using pigeon 
erythrocyte membranes and Gpp(NH)p, we were 
able to confirm these obviations (fig.2A). Following 
extensive washing, which did not affect adenylate 
cyclase activation, the EC, for isoproterenol dis- 
placement of [r251]IHYP returned to that observed 
in the absence of nucleotide. Readdition of 10 PM 
Gpp(NH)p reestablished full modulation of agonist 
binding. When a similar washout exper~ent was 
carried out with 1 PM GTPTS, persistent activation 
of adenylate cyclase was found again. However, in 
contrast o Gpp(NH)p the effect of GTPrS on 
agonist binding persisted likewise (fig.ZB), and sub- 
sequent readdition of I PM CT&S had no further 
effect. 
This is in keeping with other differences in response 
of avian erythrocyte membranes to Gpp(NH)p and 
GTPyS. For example, it is possible to reverse the 
Gpp(NH)p activation of adenylate cyclase by incuba- 
tion with L-isoproterenol and GTP or GDP [22], but 
it is not possible to deactivate the GTPyS-activated 
enzyme [22f. Similarly the GTFase activity associated 
with the activation process is essentially irreversibly 
blocked by GTPyS, but not by Gpp(NH)p [23]. 
The extent of modulation by GTP$S is concentra- 
tion dependent (when the nucleotide is present in the 
binding assay). The concentration of GTPyS which 
induces a half-maximal change in ECso for isopro- 
terenol, is -10 nM. When membranes were exposed 
to 3 nM--1 PM GTP$ in the presence of 5 PM isopro- 
terenol, and subsequently washed, receptor modula- 
tion only persisted at saturating concentrations of
GTPrS (100 nM) when adenylate cyclase is fully activ- 
ated, At subsaturating concentrations of GTP$3, or at 
saturating (1 PM) GTPyS concentrations but in the 
absence of hormone, on removal of nucleotide the 
receptor everts to or remains in its high affinity 
state. (It should be noted, that pigeon erythrocyte 
adenylate cyclase may be activated by GTPyS alone 
to 65--80% of maximal activity obtainable,) 
&Adrenergic stimulation of adenylate cyclase in 
turkey erythrocyte membranes has been shown to 
strongly depend on temperature. The temperature 
dependence was interpreted to indicate the necessity 
of a ‘fluid membrane’ for activation [24,25]. In 
table 2 temperature dependencies of L-isoproterenol 
binding in the presence and absence of GTpYS and 
of activation of adenylate cyclase are compared. The 
shift of EC’s, of isoproterenol-mediated displacement 
of IHYP in the presence of the nucleotide is progres- 
sively reduced with decreasing temperature and 
finally disappears at 1’7°C. The lack of modulation 
by the nucleotide at 17°C could be due to a retarded 
binding of GTPyS at the lower temperature. How- 
ever membranes pretreated at 37°C with saturating 
concentrations ofboth nucleotide and L-isoproterenol 
and then assayed for binding at 17”C, likewise failed 
to show an ECso value different from that of non- 
treated membranes. 
The most likely explanation therefore is that at 
17°C the receptor exists in the low affinity 
(uncoupled) form, irrespective of the presence of 
nucleotides. As the temperature israised to 27°C and 
37°C more and more of the high affmity (coupled) 
state is formed. The failure of the fi-adrenergic 
receptor to form the ‘high affmity’ (coupled) state at 
low temperature also agrees with the absence of cate- 
cholamine stimulation of adenylate cyclase (table 2). 
The increase in affinity of isoproterenol for the 
B-receptor in the presence of nucleotide on lowering 
the temperature is in agreement with observations 
1141 with turkey erythrocytes. Although a nucleotide 
dependency of agonist binding was not observed [141 
the enthalpy (A@) for L-isoproterenol binding in 
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Temperature dependency of L-isoproterenol binding and adenylate cyclase activation 
Temp. 
eo 
Displacement of [‘*‘I] IHYP-binding by L-iso- 
specific L-isoproterenol proterenol + GTPrS 
(EC,,) (PM) (EC,, ) O1M) 
Adenylate cyclase act. (pmol . mg-’ . min-I) 
in the presence of 
None L-isoproterenol L-isoproterenol 
+ GTP + GTF’ySa 
37 1.15 3.9 
21 1.05 2.5 
17 1.1 1.15 
17a 1.15 1.25 
2 
n.d. 
0.2 
n.d. 
45 
n.d. 
0.25 
n.d. 
350 
n.d. 
28 
n.d. 
a Membranes pretreated with 1 PM GTP$i and 50 PM L-isoproterenol for 10 min at 37°C and washed 3 times with 10 vol. buffer A 
before determination of binding and adenylate cyclase activity 
n.d., not determined 
Binding experiments in the presence and absence of GTPrS (0.1 PM) were done as in section 2 except that incubation was 20 min 
at 27°C and 30 min at 17°C. Maximal binding of [ 1251] IHYP was the same within + 2% at each temperature 
the presence of GTP was about the same as the AM’ 
value we found with pigeon erythrocyte membranes 
in the presence of GTPTS. 
4. Discussion 
These results demonstrate hat guanine nucleotide 
modulation of agonist binding also plays a role in 
P-adrenergic stimulation of adenylate cyclase in avian 
erythrocytes. The two forms of the fl-adrenergic 
receptor in the presence and absence of guanyl- 
nucleotides, may be designated as ‘low’ and ‘high- 
affinity’ states although they are not defined in 
molecular terms. From observations with cells lacking 
the GTP-binding protein [S] and with solubilized 
P-receptors from frog erythrocytes [26] it seems, that 
the ‘high-affinity’ form of the receptor is a receptor- 
GTP-binding protein complex. In any event, the high 
affinity form is probably an obligatory intermediate 
in the activation of adenylate cyclase and might be 
needed for the recharging of the GTP-binding pro- 
tein with GTP and the displacement of GDP, formed 
by the GTPase reaction [23,27]. However it must be 
borne in mind that GDP is likewise able to induce the 
low affinity form of the receptor (see table 1). This 
suggests he existence of an ‘empty’ GTP-binding site 
which is functional in interacting with the receptor. 
Whether this site represents a second guanine nucleo- 
tide binding site, residing in the same or another pro- 
tein as suggested by others, is not as yet clear. The 
observation that activation of adenylate cyclase by 
Gpp(NH)p is quasi-irreversible whereas receptor 
116 
modulation is not, may be explained by assuming 
only one GTP-binding protein represented by the 
protein with M,. 42 000 [ 17,281, if one considers 
further that this GTP-binding protein is in excess over 
catalytic sites (and receptors). In that case one could 
speculate that the fraction of GTP-binding protein 
which has become coupled to the catalytic moiety 
during activation [29] binds Gpp(NH)p irreversibly 
in a ‘locked’ conformation whereas the remainder of 
the GTP-binding protein binds the nucleotide revers- 
ibly making it capable of interaction with the recep- 
tor to form a ‘high affinity’ state. But whatever the 
molecular basis of modulation of agonist-receptor 
interaction by nucleotides may be, it seems likely 
that the ability of the hormone receptor to return to 
its high affinity state is a prerequisite for productive 
coupling to adenylate cyclase. Uncoupling of hor- 
monal response by genetic or chemical manipulation 
or changes of the membrane nvironment appears to 
abolish or to prevent formation of a high affinity 
state of the hormone receptor. An example is the 
desensitization f hormone receptors as a consequence 
of prolonged exposure to agonists [30,31]. Another 
example is the action of a eucaryotic ADP-ribosyl- 
transferase from turkey erythrocyte cytosol [32] 
which uncouples hormonal stimulation in aVian Wfi- 
rocytes accompanied by a loss in nucleotide modu- 
lation of /3-adrenergic receptors [33]. 
Addendum 
During preparation of this manuscript apaper 
Volume 115, number 1 FEBS LETTERS June 1980 
appeared [34] demonstrating modulation of 
/3-adrenergic agonist binding by guanylnucleotides in 
turkey erythrocyte membranes. 
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